Active Targeting By Targeting Ligands

CD Bioparticles’ services with customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms can help you to solve:

The challenges you might meet:

  • Low cell-permeability of the drugs
  • Low specificity of the targeting
  • High dosage required for treatment
  • High side-effect of the toxic chemotherapeutic agents
  • Tedious searching and conjugation of receptor-targeting-moieties

Key Features

Active Targeting By Targeting Ligands

Key benefits:

  • Wide coverage of the Antibodies, Aptamers, Affibody, Anticalins, and AdNectins meets your specific cell-membrane-transporter-targeting design
  • Receptor-targeting-moiety modifications increase the uptake rate of the drugs
  • Ready-to-use, reactive-end-group functionalized receptor-targeting-moieties simplifies your preparation procedures for labeling your drugs or your drug-loading cargos
  • Drug-oriented, customized liposome production and formulation improves the delivery efficiency of the drugs, such as nucleic acids, peptides, or molecules
  • GMP promises the quality of products
  • Analytical platforms cover from drug fabrications to in-vitro and in-vivo tests

Application candidates:

  • Large molecular, peptide or nucleic acid drugs with insufficient cell-permeability
  • Toxic chemotherapeutic agents
  • Nanoparticles with low targeting efficiency and low targeting specificity
Quote Request Form
  • Notes: Using the company/organization email address would make it easier to reach you. Thank you.

  • Notes: Provide a phone number to facilitate communication with technical needs.
Fill out the form below
to receive a quote


  • (USA)
  • (Europe)
Cookie Policy | Privacy Policy | Copyright © 2024 CD Bioparticles. All rights reserved.
Inquiry Basket